Status:

COMPLETED

Modification of Pavlovian and Instrumental Learning in Human Addiction

Lead Sponsor:

Charite University, Berlin, Germany

Conditions:

Healthy

Alcohol Use Disorder (Mild vs. Moderate to Heavy)

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The project aims at investigating modifications of environmental factors (i.e. cues and stress) relevant for learning mechanisms in addictive disorders.

Detailed Description

Project C02 aims at investigating modifications of environmental factors (i.e. cues and stress) relevant for learning mechanisms in addictive disorders. The investigators will examine non-treatment se...

Eligibility Criteria

Inclusion

  • Men and women aged 16-32 years, 33-49 years, and aged 50-65 years
  • Mild, moderate to heavy alcohol-use disorder (AUD) according to DSM-5 criteria (mild: 2-3 AUD criteria; moderate: 4-5 AUD criteria; heavy: 6 or more AUD criteria); not clinically requiring detoxification (as confirmed by an independent board-certified psychiatrist); AUD patients can have mild to moderate cannabis use disorder as well as tobacco use disorder
  • Ability to provide fully informed consent and to use self-rating scales
  • Willingness to use an android phone
  • Sufficient understanding of the German language

Exclusion

  • Lifetime history of DSM-5 bipolar disorder, schizophrenia or schizophrenia spectrum disorder, or substance dependence other than alcohol or nicotine or cannabis dependence. Severe alcohol and cannabis use disorder will be excluded.
  • Current threshold DSM-5 diagnosis of major depressive disorder, or presence of suicidal intention
  • History of severe head trauma or other severe central nervous system disorder (e.g., dementia, Parkinson's disease, multiple sclerosis)
  • Pregnancy or nursing infants
  • Current use of medications or drugs known to interact with the CNS within at least four half-life post last intake

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2023

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04032587

Start Date

October 1 2019

End Date

June 30 2023

Last Update

January 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept. of Psychiatry, CCM, Charite Universitätsmedizin Berlin

Berlin, Germany, 10117